Samarium diiodide-induced radical cyclization of oxime ether connected with formyl group: Synthesis of 4-pyrimidinyl- and 4-purinylpyrrolidin-3-ol nucleoside analogues

Tetrahedron

Volumn 54, Issue 22, 1998, Pages 5883-5892

  Miyabe, Hideto ^a   Kanehira, Sayaka ^a   Kume, Kaori ^a   Kandori, Hiromi ^a   Naito, Takeaki ^a  

^a KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOSIDE DERIVATIVE; OXIME; PYRIMIDINE DERIVATIVE; PYRROLIDINE DERIVATIVE; SAMARIUM;

ARTICLE; CHEMICAL MODIFICATION; CHEMICAL REACTION; CYCLIZATION; DRUG STRUCTURE; PRIORITY JOURNAL; STRUCTURE ANALYSIS;

EID: 0032575233     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4020(98)00274-9     Document Type: Article

References (40)

1. 1. For recent reviews, see: a) Ryu, I.; Sonoda, N.; Curran. D. P. Chem. Rev. 1996, 96, 177-194.
2. b) Snider, B. B. Chem. Rev. 1996, 96, 339-364.
3. c) Giese, B.; Kopping, B.; Göbel, T.; Dickhaut, J.; Thoma, G.; Kulicke, K. J.; Trach, F. Org. React. (N.Y.) 1996, 48, 301-856.
4. 2. Fossey, J.; Lefort, D.; Sorba, J. Free Radicals in Organic Chemistry.; Translated by Lomas, J., John Wiley & Sons: New York, 1995.
5. 3. For our examples of the reaction of oxime ethers with ketyl radical or alkyl radical, see: a) Miyabe, H.; Shibata, R.; Ushiro, C.; Naito, T. Tetrahedron Lett. 1998, 39, 631-634.
6. b) Miyabe, H.; Ushiro, C.; Naito, T. Chem. Commun. 1997, 1789-1790.
7. c) Miyabe, H.; Torieda, M.; Kiguchi, T.; Naito, T. Synlett 1997, 580-582.
8. d) Naito, T.; Torieda, M.; Tajiri, K.; Ninomiya, I.; Kiguchi, T. Chem. Pharm. Bull. 1996, 44, 624-626.
9. 4. For recent examples of the radical reaction of oxime ethers, see: a) Clive, D. L. J.; Zhang, J. Chem. Commun. 1997, 549-550.
10. b) Marco-Contelles, J.; Balme, G.; Bouyssi, D.; Destabel, C.; Henriet-Bernard, C. D.; Grimaldi, J.; Hatem, J. M. J. Org. Chem. 1997, 62, 1202-1209.
11. c) Kim, S.; Lee, I. Y.; Yoon, J.-Y.; Oh, D. H. J. Am. Chem. Soc. 1996, 118, 5138-5139.
12. d) Keck, G. E.; Wager, T. T. J. Org. Chem. 1996, 61, 8366-8367.
13. e) Bhat, B.; Swayze, E. E.; Wheeler, P.; Dimock, S.; Perbost, M.; Sanghvi, Y. S. J. Org. Chem. 1996, 61, 8186-8199.
14. f) Hollingworth, G. J.; Pattenden, G.; Schulz, D. J. Aust. J. Chem. 1995, 48, 381-399.
15. g) Chiara, J. L.; Marco-Contelles, J.; Khiar, N.; Gallego, P.; Destabel, C.; Bernabé, M. J. Org. Chem. 1995, 60, 6010-6011.
16. h) Santagostino, M.; Kilburn, J. D. Tetrahedron Lett. 1995, 36, 1365-1368.
17. 5. For the first example of the radical reaction of oxime ethers with O-stannylketyl radical, see: a) Naito, T.; Tajiri, K.; Harimoto, T.; Ninomiya, I.; Kiguchi, T. Tetrahedron Lett. 1994, 35, 2205-2206.
18. b) Kiguchi, T.; Tajiri, K.; Ninomiya, I.; Naito, T.; Hiramatsu, H. Tetrahedron Lett. 1995, 36, 253-256.
19. 6. Stach, L. J. U. S. Patent 3920772, 1975 (Chem. Abstr. 1976, 84, 89603d).
20. 1H-NMR spectroscopy. In general, the downfield shifts of signals due to the imino hydrogen of the E-oxime ether are observed by the influence of the neighboring alkoxy group on the oxime ether moiety. See: McCarty, C. G. The Chemistry of Functional Groups; The chemistry of the carbon-nitrogen double bond; Patai, S., Ed., John Wiley & Sons: New York, 1970; pp.383-392.
21. 8. The stannyl radical-induced radical cyclization of 4 gave a 3:1 mixture of trans-5 and cis-5 in 66% combined yield.
22. 9. For reviews, see: (a) Skrydstrup, T. Angew. Chem., Int. Ed. Engl. 1997, 36, 345-347.
23. (b) Molander, G. A.; Harris, C. R. Chem. Rev. 1996, 96, 307-338.
24. 10. We have observed no remarkable effect of the geometry of the starting oxime ether group on either the chemical yield or trans/cis selectivity of radical cyclization product.
25. 2, was found to be crucial for successful seven-membered ring formation. See: reference 3c.
26. 2, see: a) Marco-Contelles, J.; Gallego, P.; Rodríguez-Fernández, M.; Khiar, N.; Destabel, C.; Bernabé, M.; Martínez-Grau, A.; Chiara, J. L. J. Org. Chem. 1997, 62, 7397-7412.
27. b) Hanamoto, T.; Inanaga, J. Tetrahedron Lett. 1991, 32, 3555-3556.
28. 13. For reviews, see: a) Huryn, D. M.; Okabe, M. Chem. Rev. 1992, 92, 1745-1768.
29. b) Borthwick, A. D.; Biggadike, K. Tetrahedron 1992, 48, 571-623.
30. 14. For examples, see: a) Deng, L.; Schärer, O. D.; Verdine, G. L. J. Am. Chem. Soc. 1997, 119, 7865-7866.
31. b) Leggio, A.; Liguori, A.; Maiuolo, L.; Napoli, A.; Procopio, A.; Siciliano, C.; Sindona, G. J. Chem. Soc., Perkin Trans. 1 1997, 3097-3099.
32. c) Lowe, G.; Vilaivan, T. J. Chem. Soc., Perkin Trans. 1 1997, 539-546.
33. d) Peterson, M. L.; Vince, R. J. Med. Chem. 1991, 34, 2787-2797.
34. e) Harnden, M. R.; Jarvest, R. L. Tetrahedron Lett. 1991, 32, 3863-3866.
35. f) Mansour, T. S.; Jin, H. Bioorg. Med. Chem. Lett. 1991, 1, 757-760.
36. g) Ng, K.-M. E.; Orgel, L. E. J. Med. Chem. 1989, 32, 1754-1757.
37. h) Kaspersen, F. M.; Pandit, U. K. J. Chem. Soc., Perkin 1 1975, 1617-1622 and 1798-1802.
38. 15. a) Jacobson, K. A.; van Galen, P. J. M.; Williams, M. J. Med. Chem. 1992, 35, 407-422.
39. b) Wolfe, M. S.; Borchardt, R. T. J. Med. Chem. 1991, 34, 1521-1530.
40. 16. Shaw, G.; Warrener, R. N. J. Chem. Soc. 1958, 153-156 and 157-161.